Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8656964 | Atherosclerosis | 2018 | 6 Pages |
Abstract
Medial type IICAC has been associated with numerical increase of symptomatic intracerebral hemorrhage and decrease of early dramatic response in stroke patients receiving IV tPA. Acknowledging that these preliminary observations should be replicated in larger cohorts, it is currently reasonable to say that “the treatment” is still useful in these patients and the presence of medial IICAC does not justify withholding IV tPA.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rahsan Gocmen, Ethem Murat Arsava, Kader Karli Oguz, Mehmet Akif Topcuoglu,